Company Overview of Baxter Hemoglobin Therapeutics, Inc.
As of May 4, 1998, Somatogen, Inc. was acquired by Baxter International Inc. Previously, Somatogen, Inc., a biopharmaceutical company, developed specialty oxygen therapeutics and other pharmacological agents utilizing its proprietary recombinant hemoglobin technology.
2545 Central Ave
Boulder, CO 80301
Key Executives for Baxter Hemoglobin Therapeutics, Inc.
Baxter Hemoglobin Therapeutics, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|Imago BioSciences, Inc.||United States|
|Innovative Biologics, Inc.||United States|
|Novagen, Inc.||United States|
|ProdiGene, Inc.||United States|
|GreenLeaf Genetics, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Baxter Hemoglobin Therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.